IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
29 hedge funds and large institutions have $37.1M invested in Interpace Biosciences, Inc. Common Stock in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
29
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.09M | |
| 2 | +$530K | |
| 3 | +$33.7K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$22.2K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$10.6K |
Top Sellers
| 1 | -$1.09M | |
| 2 | -$673K | |
| 3 | -$355K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$205K |
| 5 |
CI
Cowen Inc
New York
|
-$163K |